Cellectis S.A. (ADR)
General ticker "CLLS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $340.8M (TTM average)
Cellectis S.A. (ADR) follows the US Stock Market performance with the rate: 22.8%.
Estimated limits based on current volatility of 2.4%: low 2.63$, high 2.76$
Factors to consider:
- Total employees count: 116 as of 2015
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.78$, 6.41$]
- 2026-12-31 to 2027-12-31 estimated range: [2.36$, 5.45$]
Financial Metrics affecting the CLLS estimates:
- Positive: with PPE of -6.9 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: 19.19 < Shareholder equity ratio, % of 23.37 <= 42.57
- Negative: Investing cash flow per share per price, % of -6.39 <= -4.39
- Negative: negative Industry operating cash flow (median)
Short-term CLLS quotes
Long-term CLLS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.76MM | $41.51MM | $72.95MM |
| Operating Expenses | $98.06MM | $101.06MM | $106.03MM |
| Operating Income | $-97.30MM | $-59.55MM | $-33.08MM |
| Non-Operating Income | $-19.16MM | $22.79MM | $-34.94MM |
| Interest Expense | $5.31MM | $7.45MM | $8.11MM |
| R&D Expense | $87.65MM | $90.54MM | $93.52MM |
| Income(Loss) | $-116.46MM | $-36.76MM | $-68.02MM |
| Taxes | $-0.37MM | $0.00MM | $-0.42MM |
| Net Income(Loss)* | $-101.06MM | $-36.83MM | $-67.38MM |
| Stockholders Equity | $84.69MM | $131.03MM | $75.90MM |
| Assets | $334.27MM | $383.54MM | $324.72MM |
| Operating Cash Flow | $-24.75MM | $22.10MM | $-40.14MM |
| Capital expenditure | $1.07MM | $2.58MM | $2.37MM |
| Investing Cash Flow | $-15.51MM | $-102.63MM | $-29.58MM |
| Financing Cash Flow | $82.86MM | $89.80MM | $-16.20MM |
| Earnings Per Share** | $-1.77 | $-0.41 | $-0.67 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.